Nabiximols
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00397605)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cannabinoid CB1 receptorAGONIST
CNR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cannabinoids
- cannabinoids
- cannabinoids
- cannabinoids
- cannabinoids
- nabidiolex
- tetranabinex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02956226 | Phase 2 | Jan 1, 2017 | Hebrew University |
| NCT00397605 | N/A | Nov 1, 2006 | University of British Columbia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of British Columbia | Academic/Hospital | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1